PRNP and infection: Note that the mechanism through which CGs cause this diminution of steady-state PrPC levels appears unrelated to the way another aminoglycoside, G418 (geneticin), impairs the de novo infection of cells with prions in the absence of an influence on PrPC levels or its localization [68].